Mylan hit with fresh lawsuit over EpiPen pricing
April 4, 2017Manufacturing and Production, Sales and Marketing Mylan, epipen, pricing
Just as it faces worldwide reports that over 80,000 of its EpiPens do not function properly and as the FDA …
Teva’s Huntington’s treatment becomes first FDA-approved deuterated drug
April 4, 2017Manufacturing and Production, Sales and Marketing Austedo, FDA, Teva
Israel’s Teva Pharmaceuticals has announced that the FDA has given its approval for Austedo (deutetrabenazine) in the treatment of chorea …
Sanofi to pay $20m fine for overcharging US veterans
April 4, 2017Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US
Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …
Novartis combo expands into lung cancer with EU approval
April 4, 2017Manufacturing and Production, Sales and Marketing NSCLC, Novartis, Tafinlar, mekinist
Novartis has announced that its Tafinlar (dabrafenib) and Mekinist (trametinib) drug combo has been approved by the European Commission (EC) …
Vencerx Therapeutics ring the changes appointing ex-Pfizer Director as CEO
April 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vencerx therapeutics
Vencerx Therapeutics, a biotech focused on developing treatments for neurodevelopmental disorders, has announced the appointment of Robert Ring as CEO. …
Behind Rare Disease Day 2017
April 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Rare Disease Day, rare disease
Rare Disease Day falls on the last day of February, meaning every four years it occurs on a leap year, …
Finger-prick blood test could help with depression medication
April 3, 2017Research and Development, Sales and Marketing
Researchers from the University of Texas Southwestern Medical Center have found that simple finger-prick blood test could reveal the most …
Immune system influences immunotherapy effectiveness, research shows
April 3, 2017Research and Development, Sales and Marketing immunotherapy, nivolumab, opdivo
Preliminary research conducted at the University of Pittsburgh Cancer Institute (UPCI) has discovered a link between levels of certain immune …
Pfizer secures expanded approval for Ibrance
April 3, 2017Sales and Marketing Pfizer, ibrance
Pfizer has announced that FDA has approved its supplemental New Drug Application (sNDA) for Ibrance, meaning that the drug is …
FDA issues US-wide recall of Mylan’s EpiPen
April 3, 2017Medical Communications, Sales and Marketing FDA, Mylan, epipen
After recent reports of around 80,000 defective EpiPen’s across Australia, New Zealand, Japan, Norway, Denmark, Finland and Ireland, the FDA …
Astellas lines up Ogeda for acquisition in $853 million deal
April 3, 2017Sales and Marketing Astellas, Ogeda SA, menopause
Astellas, based in Tokyo, has announced that it has agreed a deal to acquire Belgium-based Ogeda SA. The deal will …
Crunch Time: The Impact of Serialisation Requirements on Packaging Operations
March 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI services
Introduction More than three years have passed since the US federal government signed the Drug Supply Chain Security Act (DSCSA) …
Takeda lays off more than half of Ariad’s US staff
March 31, 2017Medical Communications Ariad Pharmaceuticals, Takeda
Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high …
Top Ten most popular articles on Pharmafile.com this week
March 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …
FDA approves first-ever atopic dermatitis biologic treatment
March 31, 2017Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic
Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …
AstraZeneca ends month with two pieces of news
March 31, 2017Medical Communications, Sales and Marketing AstraZeneca, Tagrisso, TerSera Therapeutics, Zoladex
AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …
Changing levels of investment in UK drug discovery
March 31, 2017Medical Communications, Research and Development ABPI, drug discovery, report
Key drug discovery investment trends
US and UK partnership to fund the fight against superbugs
March 31, 2017Medical Communications, Research and Development CARB-X, Wellcome Trust
The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …
Takeda names new President of Europe and Canada Business Unit
March 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment
Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …
Insider Interview: ABPI’s Paul Catchpole discusses NICE’s new fast-track appraisal system
March 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Insider Interview, NICE, Paul Catchpole, fast track
Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
